Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Receiving Chemotherapy”

193 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 193 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07067307
What this trial is testing

Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Mansoura University 80
Testing effectiveness (Phase 2)Study completedNCT03314805
What this trial is testing

PG2 Breast Cancer Evaluation in Adjuvant Medicine Study

Who this might be right for
Cancer-related FatigueNeutropenia, Malignant
PhytoHealth Corporation 67
Large-scale testing (Phase 3)Study completedNCT00035594
What this trial is testing

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Who this might be right for
Neutropenia
Amgen 928
Large-scale testing (Phase 3)Study completedNCT01945775
What this trial is testing

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Who this might be right for
Breast NeoplasmsBRCA 1 Gene MutationBRCA 2 Gene Mutation
Pfizer 431
Testing effectiveness (Phase 2)Looking for participantsNCT05440227
What this trial is testing

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Who this might be right for
Cancer-related Fatigue
PhytoHealth Corporation 36
Large-scale testing (Phase 3)Study completedNCT01702571
What this trial is testing

Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2,185
Not applicableLooking for participantsNCT05327608
What this trial is testing

Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
Thomas Jefferson University 55
Testing effectiveness (Phase 2)Study completedNCT04637308
What this trial is testing

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

Who this might be right for
Fluid Retention
Guangdong Provincial People's Hospital 216
Not applicableActive Not RecruitingNCT06856616
What this trial is testing

Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Neoplasms
The Third Affiliated Hospital of Harbin Medical University 6,000
Testing effectiveness (Phase 2)Study completedNCT01396655
What this trial is testing

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 78
Testing effectiveness (Phase 2)UnknownNCT04262804
What this trial is testing

Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

Who this might be right for
Breast Cancer Metastatic
Zai Lab (Shanghai) Co., Ltd. 123
Large-scale testing (Phase 3)Study completedNCT00211133
What this trial is testing

Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy

Who this might be right for
AnemiaBreast NeoplasmsQuality of Life
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 939
Post-approval studies (Phase 4)Study completedNCT02502864
What this trial is testing

Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide

Who this might be right for
Breast CancerBreast Cancer Female
H. Lee Moffitt Cancer Center and Research Institute 9
Not applicableActive Not RecruitingNCT04541212
What this trial is testing

Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

Who this might be right for
Breast CancerLymphomaLeukemia
Montreal Heart Institute 169
Testing effectiveness (Phase 2)Ended earlyNCT02978716
What this trial is testing

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

Who this might be right for
Triple-Negative Breast NeoplasmsBreast NeoplasmBreast Cancer+1 more
G1 Therapeutics, Inc. 102
Not applicableUnknownNCT06529458
What this trial is testing

Effects of Acupressure and Aromatherapy on Nausea and Vomiting Severity, Anxiety and Comfort Level

Who this might be right for
Breast Cancer Patients Receiving Chemotherapy
Setenay Batır 60
Large-scale testing (Phase 3)Study completedNCT02953340
What this trial is testing

SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 237
Testing effectiveness (Phase 2)Study completedNCT03575520
What this trial is testing

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Who this might be right for
Breast Cancer
Yonsei University 63
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Not applicableStudy completedNCT06183164
What this trial is testing

Awareness Based Stress Reduction Program Applied to Breast Cancer Patients Receiving Chemotherapy

Who this might be right for
Breast Cancer Patients Receiving Chemotherapy
Firat University 60
Next Page